Retatrutide 10 mg vial
001 · RETA-10
Purity ≥ 99%
ISO-9001
Metabolic

Retatrutide.

10 mg · Lyophilised powder

A triple-agonist investigational peptide under active study for its metabolic signalling profile.

$55.00In stock
Quantity
1

Specification

Lot-controlled
Form
Lyophilised powder
Vial
10 mg / single-dose amber vial
Purity
≥ 99% by HPLC
Storage
–20 °C, desiccated, protected from light
Origin
Synthesised under ISO-9001 facility controls
Shipping
Domestic 2–7 days · flat $15

Research context

Retatrutide is a synthetic peptide investigated in laboratory settings for its simultaneous interaction with GLP-1, GIP, and glucagon receptor pathways. Supplied as a lyophilised reference material intended solely for in-vitro and analytical research.

Lyophilised under ISO-9001 controls and dispatched in unbranded cold-chain packaging.

Notice

Intended exclusively for in-vitro laboratory research. Not a food, supplement, cosmetic, or drug. Not to be administered to humans or animals.